Mary M Albyn, | |
5468 Main St, Manchester Health Services Inc, Manchester Center, VT 05255 | |
(802) 362-2126 | |
(802) 362-4884 |
Full Name | Mary M Albyn |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 5468 Main St, Manchester Center, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558589986 | NPI | - | NPPES |
362796 | Other | NY | MVP |
11698454 | Other | VT | VMC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0720000009 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary M Albyn, 5759 Route 315, Pawlet, VT 05761 Ph: (802) 325-3569 | Mary M Albyn, 5468 Main St, Manchester Health Services Inc, Manchester Center, VT 05255 Ph: (802) 362-2126 |
News Archive
Research from the University of Copenhagen is shedding new light on the brain's complicated barrier tissue. The blood-brain barrier is an effective barrier which protects the brain, but which at the same time makes it difficult to treat diseases such as Alzheimer's.
Infants with chronic renal failure grow slowly, a problem that usually improves with aggressive nutritional therapy. When it doesn't, growth hormone is a safe and effective treatment to promote growth, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
New research has shown that receiving cross-sex hormone therapy (CHT) can help to reduce the feelings of body dissatisfaction associated with eating disorders including anorexia and bulimia in transgender people.
Experts from across Europe have developed a set of competencies in antimicrobial prescribing and stewardship, using a structured consensus procedure.
› Verified 2 days ago